Study confirms effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma
26/05/2020
Dose-adjusted EPOCH-R is already an option for diffuse large B-cell lymphomas and can be administered in an outpatient setting.
Dose-adjusted EPOCH-R is already an option for diffuse large B-cell lymphomas and can be administered in an outpatient setting.